PENPenumbra, Inc.

$13B

FY 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.2B+12.9% YoY

Gross Profit

$755M63.2% margin

Operating Income

$9M0.8% margin

Net Income

$14M1.2% margin

EPS (Diluted)

$0.36

Cash Flow

Operating Cash Flow

$168M

Free Cash Flow

$147M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$382M

Stockholders' Equity

$1.2B

Cash & Equivalents

$324M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.1B	+12.9%
Gross Profit	$755M	$683M	+10.6%
Operating Income	$9M	$74M	-87.4%
Net Income	$14M	$91M	-84.6%

PEN FY 2024 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena